Aberrant Expression of Solute Carrier Family 35 Member A2 Correlates With Tumor Progression in Breast Cancer
In Vivo · 2023
DOI: 10.21873/invivo.13076 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2023. Verfasst von Chien-Liang Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, MacKay Memorial Hospital and Mackay Medical College, Taipei, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, MacKay Memorial Hospital and Mackay Medical College, Taipei, Taiwan, R.O.C.
- Institute of Biomedical Sciences, Mackay Medical College, New Taipei, Taiwan, R.O.C.
- Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan, R.O.C.
- Department of Bioscience Technology, Chung Yuan Christian University, Taoyuan, Taiwan, R.O.C.
- Department of Surgery, MacKay Memorial Hospital and Mackay Medical College, Taipei, Taiwan, R.O.C.; changyc@mmh.org.tw.
Zitieren
APA
Liu, C. L., Cheng, S. P., Huang, W. C., Chen, M. J., Lin, C. H., Chen, S. N., & Chang, Y. C. (2023). Aberrant Expression of Solute Carrier Family 35 Member A2 Correlates With Tumor Progression in Breast Cancer. In Vivo. https://doi.org/10.21873/invivo.13076
Vancouver
Liu CL, Cheng SP, Huang WC, Chen MJ, Lin CH, Chen SN, et al. Aberrant Expression of Solute Carrier Family 35 Member A2 Correlates With Tumor Progression in Breast Cancer. In Vivo. 2023. doi:10.21873/invivo.13076
BibTeX
@article{Liu2023,
author = {Liu, Chien-Liang and Cheng, Shih-Ping and Huang, Wen-Chien and Chen, Ming-Jen and Lin, Chi-Hsin and Chen, Shan-Na and Chang, Yuan-Ching},
title = {Aberrant Expression of Solute Carrier Family 35 Member A2 Correlates With Tumor Progression in Breast Cancer},
journal = {In Vivo},
year = {2023},
doi = {10.21873/invivo.13076}
}
EUVIMED